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Abstract
Background: HIV-related stigma continues to negatively impact the health and well-being of people living with HIV,
with deleterious effects on their care, treatment and quality of life. A growing body of qualitative research
has documented the relationship between HIV-related stigma and health. This review aims to synthesize
qualitative evidence that explored the intersections of stigma and health for people with HIV.
Methods: A thematic summary was conducted that was guided by the qualitative metasummary technique
developed by Sandelowski and Barraso. Literature searches yielded 8,622 references of which 55 qualitative
studies were identified that illustrated HIV-related stigma in the context of health.
Results: The metasummary classified qualitative findings into three overarching categories: conceptualizing
stigma which identified key dimensions of HIV-related stigma; experiencing stigma which highlighted experiences of
stigma in the health context, and managing stigma which described ways in which stigma is avoided or addressed. To
better illustrate these connections, the qualitative literature was summarized into the following themes: stigma within
health care settings, the role of stigma in caring for one’s health, and strategies to address HIV-related stigma in the health
context. A number of health care practices were identified – some rooted in institutional practices, others shaped by
personal perceptions held by practitioners – that could be stigmatizing or discriminatory towards people with HIV.
There existed interconnections between enacted stigma and felt stigma that influenced health care utilization,
treatment adherence, and overall health and well-being of people with HIV. Intersectional stigma also emerged as
instrumental in the stigma experiences of people living with HIV. A number of strategies to address stigma were
identified including social support, education, self-efficacy, resilience activities, and advocacy.
Conclusion: This review of the qualitative evidence indicates that HIV-related stigma within health contexts is a broad
social phenomenon that manifests within multiple social spheres, including health care environments. Findings from this
review indicate that future stigma research should consider the social structures and societal practices – within and
outside of health care environments – that perpetuate and reinforce stigma and discrimination towards people with HIV.
Background
In the early years of the HIV/AIDS epidemic, the social
consequences of stigma and discrimination towards
people with HIV were identified as part of the “third phase
of the epidemic” and addressing these consequences was
as “central to the global AIDS challenge as the disease
itself” [1]. With the introduction of combination antiretro-
viral treatments (cART) in 1996, there was optimism that
HIV/AIDS and the resulting stigma and discrimination
could be addressed. Despite advancements in treatment
and the evolution of care to combat HIV/AIDS world-
wide, in addition to the proliferation of HIV-related edu-
cation, work remains to combat the stigma associated
with HIV infection. Due to the perceptions and judge-
ments of HIV that continue to persist, stigma remains one
of the biggest challenges in the social response to HIV/AIDS.
The concepts of stigma applied in HIV research have
been shaped by the seminal work of Erving Goffman
(1963) who defined stigma as a discrediting “mark” or
attribute which reduces the status of the person in the
eyes of society [2]. Though health-related stigma has
been associated with other health conditions such as
mental illness, cancer, and other sexually transmitted in-
fections, much of the recent illness stigma literature has
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been devoted to the stigma and discrimination associ-
ated with HIV and AIDS (HIV-related stigma) and the
development of conceptual frameworks specific to HIV-
related stigma [3–9]. These conceptual frameworks have
identified particularities of stigma in the context of HIV
including: the moral valuations ascribed to the illness,
modes of transmission, and populations impacted; the
intersections of HIV-related stigma with other forms of
social marginalization; and the recognition of societal
power relations within mechanisms of stigma [3–9].
There has been a growing body of literature exploring
stigma and health for people with HIV. This literature indi-
cates that stigma continues to have a detrimental impact
on the health and well-being of people with HIV, and their
access to health and social services [10, 11]. Studies have re-
ported on discrimination in healthcare environments to-
wards people with HIV manifesting as denial of care,
confidentiality breaches, negative attitudes, and humiliating
practices by health care workers [12–14]. Other studies
have identified the impact stigma can have on a person’s
self-concept or mental health once his or her status is
known [15, 16]. Stigma has been shown to impact mental
health factors for people with HIV including anxiety [17–
19], depression [20–22], suicidal ideation [23, 24], emo-
tional health [25], psychological well being [26], life satis-
faction [27], and quality of life [28, 29]. Stigma has also
been linked to health care seeking and adherence to anti-
retroviral medication [30–33]. Consequently, stigma
related to HIV remains a daunting barrier to HIV pre-
vention [34]. Fears of disclosure, anticipated stigma, inter-
nalized shame, and experiences of discrimination within
health care settings and in greater society can influence fu-
ture decision making around prevention activities [35–38].
Although there has been a number of recent reviews
that examined stigma and HIV [16, 39–41, 42], there has
been limited research that systematically integrates
qualitative evidence in its exploration of stigma, HIV
and health. Qualitative synthesis, a method of aggregating
qualitative evidence, is a burgeoning approach to synthe-
sizing research evidence and has grown in popularity
within health research [43–47]. While syntheses of
quantitative evidence have been used to understand
causal mechanisms, to measure effect size, or to deter-
mine intervention effectiveness, qualitative syntheses
are better suited for understanding the nature of a
phenomenon, to explore contextual features of experi-
ence and to develop theoretical concepts derived from
findings across studies [48–50]. A synthesis of the
qualitative literature on HIV, stigma and health is par-
ticularly important given the evolution of the epidemic,
its global nature and the diversity of cultures and pop-
ulations that have been impacted by HIV/AIDS. Quali-
tative evidence is particularly helpful in understanding
the socially constructed nature of HIV infection,
interpreting the social processes, interactions, or context-
ual features that influence health care decision making,
and delineating the interconnections between stigma-
related processes and related health impacts.
The original objectives of this project were to conduct
a synthesis of the qualitative and quantitative research
evidence to better understand the impacts of stigma on
the health of people with HIV. This paper reports on the
qualitative evidence that explored the intersections of
stigma and health for people with HIV. In the context of
this review, HIV-related stigma is defined as the prejudi-
cial feelings, stereotypical perceptions, discriminatory be-
haviors and actions, or social devaluation of HIV infection,
HIV/AIDS related illnesses, the activities associated with
HIV-infection, and people with HIV [2, 6, 51].
Methods
Search strategy
From February 2009 to May 2010, a series of electronic
and manual searches were carried out to yield qualitative
and quantitative literature related to HIV, stigma and
health. A librarian conducted a search of six electronic
database (CINAHL, EMBASE, Medline, PsycINFO,
Sociological Abstracts, and WHOLIS) using keyword
terms related to HIV/AIDS (e.g., human immunodefi-
ciency, acquired immunodeficiency syndrome), and
stigma/discrimination (e.g., stigma*, ostracism, preju-
dice, stereotyping, discrimination).
To ensure that important evidence not captured in an
electronic database search was not missed, manual
search strategies were also performed including: citation
searches of systematic reviews addressing the topic of
stigma for people with HIV [16, 39, 40, 41, 42, 52], a bib-
liographical review of articles included after full paper
review, and recommendations from content experts
knowledgable in HIV-related stigma. The date range of
the literature search spanned from January 1996 to
2010. The literature search was restricted to post-1995,
since the introduction of cART is often cited as a key
turning point in the HIV epidemic. To avoid the exclu-
sion of relevant health-related literature at this stage,
the search strategy used key terms for HIV and stigma
exclusively, and then incorporated health-related in-
clusion criteria in the review stages (see Additional
file 1 – Screening process for qualitative sysnthesis).
Reviewing
The inclusion process went through three review stages:
title and abstract review to determine clear inclusion,
full-paper review to determine general applicability to
the synthesis aims, and methodological review to deter-
mine applicability based on the pre-specified inclusion
criteria. The inclusion criteria were as follows: 1) qualita-
tive studies; 2) published after 1996; 3) that reported
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thematic findings on stigma and health; 4) and had par-
ticipants with experiential knowledge of stigma based on
their own experience (people with HIV) or from the per-
spective of living with or working with people with HIV
(i.e., clinicians, community workers, caregivers, family
members of people with HIV). Although language re-
strictions were not applied as an inclusion criterion, this
review was only able to synthesize studies that were
written in English, French or Spanish.
Qualitative analysis
Prior to extracting the data, the authors developed an
analytical focus guided by the following questions:
 How is stigma defined in the qualitative literature
exploring stigma, health and HIV?
 What are the health-related experiences of stigma
for people with HIV?
 What are the ways people with HIV navigate
health-related experiences of stigma?
The working definition of health used for this synthe-
sis derived from the health domains (physical health,
mental health and substance use, health care access/
utilization, and adherence to antiretroviral medications)
identified in a parallel quantitative systematic review on
the effects of HIV-related stigma on health outcomes
that was conducted by some of the authors [53]. The
analysis of qualitative literature also accounted for any
other health-related findings that may further delineate
the interconnection between stigma and health (i.e.,
achieving wellness while experiencing stigma, secondary
health-related factors that may act as a pathway between
stigma and health). The conceptualization of stigma used
for analysis was shaped by broad conceptual frameworks
of stigma such as those proposed by Goffman [2];
Alonzo and Reynolds [3]; and Link and Phelan [54];
and HIV-specific frameworks of stigma such as the
work of Herek et al. [8, 9]; and Parker and Aggleton [4].
The authors chose these frameworks as they captured the
particularities of stigma in the context of HIV and delin-
eated the social mechanisms that could potentially con-
tribute to emotions, beliefs and behaviours that shape
health-related experiences for people with HIV.
A thematic summary guided by the qualitative metasum-
mary technique developed by Sandelowski and Barraso was
completed. Qualitative metasummary is a synthesis method
used to aggregate qualitative findings and to create a the-
matic taxonomy across studies [46, 55]. Thematic analytical
approaches were also used to identify, interpret, and report
overarching themes and patterns of meanings emerging
from the included literature [50, 56, 57]. An inductive ana-
lytical approach was used so that the themes identified for
the synthesis were strongly linked to the thematic findings
reported within each study [58].
During the data extraction process, authors’ statements
of findings were isolated including quotes specifically
related to those findings. Next, similar findings were
grouped using a coding key developed from the analysis.
The coding key was established using the themes identi-
fied in the original studies. Each reviewer coded each
study independently, then met to compare coding to
ensure consensus. Using constant comparison methods,
codes were grouped into themes, then findings were orga-
nized thematically based on replication (confirming what
is said in other studies), extension (providing additional
contextual information that extends findings) or refutation
(providing a contrary view to what is said in other studies).
Conceptual frameworks for stigma also guided the inte-
gration of findings into the overarching themes.
Three reviewers were involved in the data extraction
and analysis of qualitative findings (LAC, DNB, and
RD), and a fourth reviewer (ER) was involved in the
verification of data extraction and thematic coding.
Each included reference was reviewed and appraised in
duplicate by two independent reviewers. Data extrac-
tion was conducted by one reviewer and verified by a
second reviewer. Any disagreements between reviewers
were resolved by consensus and, if that failed, a third
independent reviewer resolved the disagreement. The-
matic analysis was conducted by a team of two reviewers
with audits conducted by a third reviewer to ensure
authenticity of extracted data to the original study, and to
ensure consistency of thematic analysis. The qualitative
team met regularly to discuss review findings. As part of
the peer review process, members of the team for the
quantitative review also joined the qualitative review
meetings at three review stages: completion of data extrac-
tion, completion of thematic coding, and preliminary ana-
lysis of qualitative findings.
Results
Identification, screening and eligibility
The literature searches yielded 8,622 references (5,729
after duplicate references were removed) of which 131
papers were included for qualitative or quantitative data
extraction. From the 131 studies that met the criteria for
inclusion, 76 were excluded from the qualitative synthe-
sis (see Additional file 2 for a listing of articles excluded
from qualitative data extraction): 65 studies that reported
only quantitative findings and 11 studies published in lan-
guages other than English, French or Spanish. 1 In total,
55 studies were included in the qualitative synthesis: 53
qualitative studies, and two mixed method studies
[35, 59–112]. The inclusion process has been docu-
mented in Fig. 1.
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Study characteristics
The settings for included studies were geographically di-
verse, with a mixture of studies conducted in high-, mid-
dle- and low-income countries (see Additional file 3 for
a summary of study characteristics). Twenty-nine studies
were conducted in the Americas (Canada (n = 3), Mexico
(n = 2), Grenada, and Trinidad and Tobago (n = 1), and
the United States (n = 23)), 10 studies in South-East Asia
(Cambodia (n = 1), China (n = 4), and Vietnam (n = 5)),
eight in Africa (Botswana (n = 1), Ghana (n = 1), South
Africa (n = 2), Uganda (n = 2), Zambia (n = 2)), four in
Western Europe (Ireland (n = 1), and the United
Kingdom (n = 3)), three in South Asia (India), and one in
Europe/Central Asia (Russian Federation). Twenty-seven
studies focused on a specific population, including
women (n = 11), children and youth (n = 6), ethnoracial
communities in Western countries (n = 5), people who
use drugs (n = 2), transgender persons (n = 1), people
with incarceration histories (n = 1), and older people
with HIV (n = 1). Of the 55 studies included in this
Fig. 1 Screening process for qualitative synthesis. Figure 1 illustrates the screening and review process for the qualitative synthesis, number of references/
papers excluded at each review stage, and reasons for exclusion
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qualitative synthesis, only two specifically aimed to study
the intersections of HIV, stigma and health [108, 112].
The remaining 53 papers indirectly reported on the
intersection of health and stigma within their thematic
results: 16 studies explored stigma or discrimination and
37 explored health-related topics. Of the studies where
health was the primary aim of the paper, 15 studies
focused on adherence [63, 64, 72, 75, 84, 83, 89, 93, 95,
97, 98, 100, 101, 104, 111], 16 on health care access and
utilization [35, 59, 62, 73, 80, 81, 85-87, 91, 92, 94, 96,
103, 106, 109], three studies on general quality of life
[66, 69, 78], two studies on substance use [71, 110], and
one study on mental health [70]. Nineteen studies
applied an explicit concept of stigma to their study find-
ings. Goffman’s conception of stigma [2] was most cited;
other concepts of stigma and discrimination applied in
the qualitative findings include the UNAIDS’ Protocol
for the Identification of Discrimination against People
with HIV [113]; Link and Phelan’s conceptualization of
stigma [54]; Parker and Aggleton’s conceptualization of
HIV/AIDS related stigma and discrimination [4], and
Alonzo and Reynolds’ definition of stigma [3]. Of these
nineteen studies, four developed conceptual stigma frame-
works using the original study findings [77, 104, 107, 110].
Synthesis of qualitative literature
While the qualitative studies on HIV-related stigma were
geographically and topically diverse, review findings sug-
gest that the included studies shared some common
conceptions of stigma within the health context. In this
synthesis, we initially categorized the qualitative findings
using the themes commonly identified across the included
literature; then, in the thematic analysis, we identified
overarching themes in relation to HIV, stigma and health.
The metasummary classified qualitative findings into three
overarching themes: conceptualizing stigma which identi-
fied key dimensions of HIV-related stigma; experiencing
stigma which highlighted experiences of stigma in the
health context, and managing stigma which described
ways in which stigma was circumvented, buffered or com-
bated. (See Additional file 4, for a matrix summary classi-
fying the common themes identified in the included
literature; see Additional file 5, for a detailed description
of these themes).
The reviewed studies identified six dimensions of
HIV-related stigma: enacted stigma (discriminatory be-
haviours, actions or attitudes from others), felt stigma
(internalization of stigma; devaluing beliefs, behaviours
or actions in which people with HIV may hold or en-
gage), marginalization (other forms of social devalu-
ation), disclosure (disclosure of seropositive status),
morals and values (social mores and societal values),
and visible health (visible symptoms of seropositivity).
These dimensions informed how stigma was experienced
by people with HIV and addressed within health care con-
texts. The qualitative literature illustrated stigma as a social
process, and study findings delineated the ways in which
the dimensions of HIV-related stigma manifested within
health care access and utilization, adherence to treatments,
and maintenance of one’s health and well-being. Lastly,
these studies offered various strategies through which
stigma was managed. This synthesis of the qualitative litera-
ture indicates that the six dimensions of HIV-related stigma
are interconnected thereby illustrating the complex dynam-
ics between marginalization, disclosure, social mores and
values, and visible health in enacted and felt stigma.
To better illustrate these connections, summarized here
are aspects of HIV, stigma and health that were prominent
in the qualitative literature. The first section, HIV and
stigma in health care environments describes some of the
ways in which health care practices can be discriminatory
towards or interpreted as stigmatizing by people with HIV.
The second section, HIV and stigma and its role in caring
for one’s health, identifies some of the processes and prac-
tices people with HIV may use to navigate stigma and dis-
crimination while caring for their health and well-being. In
the last section, strategies identified to address HIV-related
stigma are explored. These modes of addressing stigma
offer people with HIV, as well as health care practitioners
and other advocates in their care, alternative ways of man-
aging stigma that could contribute to stigma reduction.
HIV and stigma in health care environments
The literature identified a number of strategies used
within health care settings to manage HIV/AIDS. Some
of these practices were rooted in prevention strategies,
others seemed shaped by personal perceptions that
health practitioners held towards HIV/AIDS or people
with HIV. Three practice strategies emerged from the
literature: risk management, where strategies to mitigate
perceived health risks were institutionalized in care; fear
management, where care practices stemmed from practi-
tioner fears of HIV exposure; and moral management,
where care practices derived from judgmental percep-
tions towards people with HIV and transmission activ-
ities. The literature also identified intersectional stigma,
or interconnections between HIV-related stigma and other
forms of social marginalization as they inform access to
health care. Whether these practices were codified in insti-
tutional systems or engaged indiscriminately by health care
providers, they were distinguished as stigmatizing health
care practices as they had the potential to expose people
with HIV to discrimination or enacted stigma.
Risk management
A number of risk management procedures institutional-
ized in organizational policies were characterized as be-
ing potentially discriminatory towards people with HIV.
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Segregation of people with HIV was an example of a
precautionary measure that could incite stigma. Some
studies considered segregation with one’s own [2] – others
who live with HIV – a means of coping with the condition,
particularly for people who had been recently diagnosed.
Other studies noted acts of segregation that may intially
have been instituted to protect people with HIV, such as
protecting them from opportunistic infections. The qualita-
tive literature also discussed segregation practices as
intentionally used to differentiate people with HIV from the
general care population. Brickley’s (2007) study remarked
that segregation practices within health care settings served
as a means of stigmatizing people with HIV [35]:
“You know, at [the] hospital, when we come, everybody
knows who we are. Infected people want as few people
to know about their situation as possible. With other
diseases like hepatitis, the patients may die sooner but
aren’t as discriminated. This disease is repellent.
Therefore at [the] hospital, there is a room reserved for
the patients of this [HIV/AIDS] disease. Anyone
coming there is infected. When we’re waiting outside
the room, we will be identified as infected. That room
is for this disease. You go elsewhere for other diseases
or for consultation. That room is for this disease.”
(22- year-old post-partum woman quoted in Brickley
(2007), p. 107)
As illustrated above, segregation as an institutional
practice could demark people with HIV. Furthermore,
by separating people with HIV from the general pub-
lic, health institutions could inadvertently disclose
serostatus.
Confidentiality violations were another form of dis-
closure within health care settings discussed as inciting
stigma. Institutional practices such as labeling client re-
cords or lab work – infection control marking, warning
labels on blood or urine tests, or labels on medications
– could potentially disclose one’s status. These care
practices could subsequently violate patient’s confidenti-
ality, particularly in places where these markings are
publically displayed [74]:
“So when I got there [to the medical clinic] they hand
me my chart and I’d go see the blood pressure nurse,
then I’d go see the nurse that draws blood, then I’d go
see the doctor. I’d walk around with this big chart with
this big sticker on it—HIV positive. Everyplace I went I
was carrying this. I felt why don’t they just tattoo my
forehead.” (“Louis” quoted in Emlet (2007), p. 747)
Whether confidentiality was violated consciously or
unconsciously, enacted by individuals or codified in
health care practices, it had a profound impact on how
people with HIV experienced health care and on their
future health care seeking behaviours.
The qualitative literature identified ways in which
health care strategies designed to mitigate health risks
could become discriminatory care practices. However, Li
et al. (2009) cautions on distinguishing between stigma-
tizing behaviors and discriminatory intent; stigmatizing
behaviors can be determined by a combination of factors
such as personal attitudes, social norms, and situational
cues. Additionally, historical experiences of discrimin-
ation may influence the interpretation of behaviors as
discriminatory [114]. Nevertheless, the literature illus-
trated ways in which institutional practices became stigma-
tizing forces for a person with HIV even if discrimination
was not intended. Behaviors that may seem benign to a
health care practitioner may be stigmatizing for a person
with HIV, particularly if these actions mirror prior discrim-
inatory experiences within health care settings or are
reflective of HIV-related stigma within greater society.
Although these institutional risk management strategies
could have been considered ethical care protocol without
malfeasance, synthesis findings suggest that risk manage-
ment strategies that declared one’s status through segrega-
tion or demarked one’s status through labeling could
become forms of disclosure that potentially exposed people
with HIV to stigma.
Fear management
The qualitative literature also illustrated that mispercep-
tions of HIV transmission could fuel fears of infection.
Though these fears were typically described as manifest-
ing in individuals with limited knowledge of HIV trans-
mission, they were also expressed by health care
professionals expected to be more knowledgeable about
modes of transmission. For example, Rintamaki et al.
(2007) indicated that HIV-positive participants often
attributed expressions of nervousness among health care
staff to fears of transmission [96]:
“The dentist that was actually going to work on me, I
felt like, the vibe that I got from him, the energy that I
got from him, or at least, the demeanor that I got from
him, was that he really didn’t want to work on me or
he wasn’t comfortable working on me. And that was
real disconcerting because I thought, “Where am I
going to go to be able to get this done?” (“Jerome”
quoted in Rintamaki (2007), p. 961)
Other examples of fear management were excessive
precautions used by practitioners such as wearing protect-
ive clothing for general care, double gloving, or placing
protective covering for services that only involved casual
touch. Excessive precautions enacted at the discretion of
individual health care practitioners may have resulted
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from limited enforcement of universal health care pre-
cautions. However, these precautionary practices, when
excessively or discriminately practiced may stigmatize
people with HIV. These selective or discretionary uses
of precautionary measures could also expose HIV-
positive individuals to disclosure as well as to stigma.
Moral management
The literature discussed moral management within
health care environments as a form of “judgementalism”
[35] linked to the societal moralization of HIV infection.
In these examples, health care practitioners were posi-
tioned as social judges perceived to be blaming patients
for their infection. People with HIV discussed being
moralized within health care environments in a number
of ways: being ignored or infantilized, drawing dispara-
ging comments, receiving neglectful care or being denied
care due to a perceived denigrated lifestyle. Some studies
also noted the power dynamic of health care centers,
where the social positioning and professional status of
health care practitioners permitted them to dictate “what
is best for the patient” [69]. As remarked in Rutledge et al.
(2009), this social positioning could contribute to pro-
viders using their societal power to engage in condemning
practices while providing care at the same time [99]:
“About two years ago I went to get a test for genital
warts. . . . [T]here was . . . a male nurse. . . . He told me
to pull down my pants and press my hands against the
wall. He said, ‘Open your ass; I am going to test you’. So
I did as he said, he shined the light and . . . the nurse
decides to say, ‘Why you doing it with a man?! That is so
wrong! . . . That’s why you get this thing now because
you are not supposed to be buggering your ass!’ They put
the medication on and said to come back in a week. . . .
I am frightened for two years to go back and get the
results of the test.” (Trinidadian MSM as quoted in
Rutledge (2009), p. 24)
Judgementalism of people with HIV often converged
with other forms of societal moralization. Rajabiun et al.
(2007) noted that some people with HIV attributed
prejudicial treatment from health care practitioners to
their historic or current drug use [94]:
“When I went to the hospital, I told them I was HIV . .
. he (the doctor) said, ‘So you are HIV and you use
Crystal (meth).’ ‘Yes.’ And he looked down on me. And
so he caused me a complex . . . he didn’t want to
touch me.” (Unidentified participant quoted in
Rajabiun (2007), p. S-24)
Other studies noted inequitable care towards people
who use drugs such as reluctance of providers to treat
or to prescribe medications which people with HIV
attributed to their drug use [71, 109].
The moral stratum to which certain people with HIV
belong could also influence the quality of care they
received and the level of stigma they endured. As dis-
cussed in Surlis (2001), perceived modes of HIV acquisi-
tion – drug use, sexual activity, transmission via blood
transfusion, and vertical transmission – were morally strati-
fied based on the level of fault attributed to the HIV-
positive individual [106]. Women were particularly suscep-
tible to moralization of their HIV-status: as sexually im-
moral if not partnered, as a vector of transmission if
partnered, or as bad parents if expectant mothers or bio-
logical mothers of children with HIV [35, 82, 85, 87]. Moral
judgements of people with HIV was indicative of symbolic
stigma or the synergistic relationship between HIV-related
stigma and the stigma attributed to the populations linked
to HIV transmission [9]. Additionally, the moralization of
people with HIV often intersected with dominant value sys-
tems: social role expectations, systems of privilege and
oppression, and hierarchical constructions of social differ-
ence within broader society.
Intersectional stigma
HIV-related stigma was also expressed in relation to
other forms of social marginalization. Study authors
used terms such as “double stigma”, “multiple stigmas”,
and “intensified stigma” to describe the interlinking of
HIV-related stigma with other forms of marginalization
due to race, ethnicity, socioeconomic status, class or
caste, gender identity, sexual orientation or age. Thus,
HIV-related stigma did not work in isolation; it was mu-
tually constituted within other forms of marginalization
to create interlocking matrices of oppression [115, 116].
As identified in Cain et al. (2001), the discrimination
experienced by HIV-positive participants within health
care environments seemed interlinked with other social
prejudices [66]:
“The hospital treats you bad. There are attitudes and
gestures toward me being black, HIV positive, gay and
a recovering drug user.” (African-American Male
quoted in Cain (2001), p. 301)
In some instances, these experiences of stigma within
health care environments followed a “continuum of
harm” [99] where participants ranked the manifesta-
tions of discriminatory behavior differently based on
prior experiences of discrimination or the hiearchical
positioning of one’s social group within broader society.
This use of terminology to illustrate the intersectional
relationship between HIV-related stigma and other forms
of marginalization echoes Parker & Aggleton’s assertion
that conceptualization of stigma and HIV must consider
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broader notions of power, privilege and oppression [4].
HIV-related stigma played a key role in reproducing social
difference: it designated people with HIV as the ‘social
other’, and denoted the social, political and systemic factors
that allowed power relations to occur between those who
were stigmatized and those who enacted the stigma [88].
Experiences of enacted stigma within health care envi-
ronments cross-cut the literature: it was identified in
both high-income and low-income countries, and described
in the earlier and the more recent studies. Synthesis find-
ings indicate that discrimination within health care environ-
ments were a reflection of existing societal perceptions of
HIV transmission, of people with HIV, and of activities and
populations associated with HIV. Within the qualitative lit-
erature health care environments became another social
space where perceptions of HIV and of people with HIV
were demonstrated. Moreover, the health care environment
existed as an institutional system where social values and
mores, systems of power, and constructions of difference
were instituted and operationalized. Consequently, stigma-
tizing attitudes against people living with HIV were demon-
strated by those individuals and systems to whom people
with HIV were expected to entrust their health.
HIV, stigma and caring for one’s health as a person with HIV
Enacted, anticipated and felt stigma also played a role in
caring for one’s health. The literature identified several
stigma management strategies in which HIV-positive par-
ticipants engaged to mitigate the negative effects of
stigma. These included avoiding health care services
where one’s status could be discerned and managing the
“dilemma of visibility” [65] – signs and symptoms of HIV,
opportunistic infections, or co-occurring illnesses –
through health care practices. While some included stud-
ies identified stigma management strategies that could fa-
cilitate health and well-being, much of the qualitative
evidence identified the detrimental effects of managing
stigma through health care practices.
Managing stigma through health care utilization
The literature linked both felt and enacted stigma with
health care utilization; fears of disclosure and anticipated
stigma deterred some HIV-positive individuals from seek-
ing treatment and utilizing care. Feelings of shame, blame,
fear, and denial were also described as instrumental in
delaying health care utilization.
Utilization practices were also devised as a means of
avoiding stigma such as: using informal care, deffering
disclosure of one’s status to health care practitioners,
choosing larger medical centers, commuting to care
outside of their community, and avoiding HIV-related
health organizations, (i.e., HIV/AIDS service organization
(ASOs), HIV/AIDS specialty care). Another form of stigma
management included refusing treatment altogether [87]:
“Today we had a very sick lady, and we wanted to give
her IV fluids. . . . But she refused to stay here, simply
because when she’s being visited, people will know she
has HIV.” (Nurse quoted in Mill (2003), p. 12)
Additionally, previous experiences of stigma within
health care environments deterred utilization of care;
these experiences of discrimination sometimes led indi-
viduals to avoid the clinic or hospital in question or to
stay away from health care environments altogether,
regardless of where it was delivered.
Managing stigma through adherence
Stigma also had a profound impact in achieving optimal
adherence to antiretroviral treatments. As medication
adherence could signify HIV-status, it subsequently be-
came a form of inadvertent disclosure that could result in
enacted stigma. Thus, medication use was discussed as
being administered accordingly to manage potential dis-
closure. People with HIV engaged in various behaviors
and actions to maintain status secrecy such as hiding
medications in unmarked or alternative containers or dis-
guising medications as breath mints or vitamins. As noted
in Ingram et al. (1999), some participants would com-
monly use another illness believed to be less stigmatizing
to explain their medication use [82]:
“I just tell them that I got lymphoma. I guess we all
sort of use the cancer theory.” (Unidentified
participant quoted in Ingram (1999), p. 98)
For some people with HIV, adherence and stigma
avoidance became “competing priorities”, where they
compromised adherence in order to avoid disclosure
and anticipated stigma [110].
Adherence and stigma was a predominant theme in
studies exploring the stigma experiences of children and
youth with HIV. These studies identified the distinct ad-
herence challenges for young people and the unique ways
they and their caregivers had to navigate stigma while
preserving young people’s sense of self. Anticipated stigma
associated with the child’s adherence was a predominant
concern for HIV-positive parents, especially for biological
mothers of children with HIV. For mothers with HIV, ad-
herence could elicit feelings of guilt, particularly for
women who may blame themselves for their child’s HIV
serostatus [111]:
“Because he has the virus, since I gave it to him. If it
wasn’t for the virus, he wouldn’t have to take it. And it
reminds me every time I make him take the medicine.
And I think that reminds him that he has the virus, so
it bothers me”. (Biological mother of a 13-year-old boy
quoted in Wrubel (2005), p. 2427)
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The stigma management strategies that caregivers
utilized to shield their children from stigma were consid-
ered a form of “protective silence” [74], where caregivers
managed adherence accordingly to avoid disclosure for
fear of their child internalizing stigma, or to ensure their
own status remained unknown. Yet, for young people
unaware of their status, protective silence and adherence
became particularly problematic. In cases where care-
givers had not disclosed their child’s HIV serostatus to
him or her, they had to be hypervigilant in maintaining
optimal adherence without disclosing the purpose of the
medication, sometimes resulting in parental force, child
rebellion, or distrust [63]. Tippett Barr et al. (2007) ex-
plained that in cases where the caregiver had not disclosed
the child’s status to other care supports, they became
solely responsible for their child’s adherence [108]. This
responsibility became challenging if they were unable to
consistently care for their child’s health.
Impact of stigma management on health
Managing stigma through health care utilization or ad-
herence could also have a deleterious impact on health
including anxiety, substance misuse, depression and
thoughts of suicide. For instance, depression related to
HIV seropositivity was considered a significant barrier
to maintaining optimal health, and potentially detrimental
to accessing services and adhering to antiretroviral reg-
imens. Felt stigma, as demonstrated through fear,
self-isolation, or self-blame, could also contribute to
depression.
Napravnik et al. (2000) noted that fear, sadness and
guilt were particularly salient to the mental health of
mothers with HIV [91]:
“I was not ready to have a baby . . . [After] finding out
about being pregnant [I] became bitter with myself. I
cried a lot. I cried all the time. Because I felt it was
just so unfair . . . Because here is a child, an innocent
child, and you not know that, you know, she could be
or he could be HIV-positive. You know? And it’s
nothing that they did. They didn’t ask to come here.
So, that was the main thing . . . I cried . . . I was
very depressed during my pregnancy.“(“Janice”
quoted in Napravnik (2000), p. 416)
Fears of passing the infection to their children was iden-
tified as a potential barrier to accessing prenatal HIV care.
Though expectant mothers may have wanted to ensure
their children were born HIV negative, felt stigma inter-
secting with experience of sadness or distress as they navi-
gate the health care system that challenged health care
utilization and adherence to treatment.
Experiences of enacted or felt stigma also contributed
to suicidal ideation [69, 100]. Some people with HIV
offered suicide as a stigma management strategy, to avoid
the “disfiguring features” associated with later stages of
infection or as a way of keeping the diagnosis secret [107].
Sabin et al. (2008) indicated that in some cases, suicide be-
came a means of “saving face” or to avoid shaming or bur-
dening loved ones, particularly in family oriented cultures
[100].
In some instances, substance use became a coping
mechanism for HIV-related stigma. As noted in the
mental health study conducted by the Committee for
Accessible AIDS Treatment (2008), for some people
with HIV, alcohol and drug use helped them cope with
their status, along with other mental health concerns
deriving from their HIV-diagnosis and subsequent
stigma [70]:
“I grew up with all these ideas about masculinity –
men don't get depressed, men have to be aggressive,
men don't have nervous breakdowns, men don't suffer
from anxiety. To be a man is to be invincible. I started
using drugs and alcohol … when I don't want to talk
to people, when I am isolated, when I feel afraid of
expressing my fears. Having to keep my feelings inside
myself leads me to this self-destruction.” (Spanish-
speaking man quoted in CAAT (2008), p. 19)
While in some instance, substance use became a cop-
ing mechanism, in others it heightened experiences of
felt stigma. Maher et al. (2007) noted that some people
with HIV internalized the social moralization attributed
to drug use. In their study, the label of social evil, a term
ascribed to high-risk behaviors in Vietnam, was articu-
lated in the narratives of study participants, where they
referred to themselves as “social evils” [86]. Thus, their
felt stigma and sense of self were an embodiment of the
social devaluation of drug use and of HIV/AIDS.
For some people with HIV, stigma management
through health care practices could provide some health
benefits. Denial was a strategy that allowed some people
to avoid the anxiety and stress stemming from enacted
stigma. Denial through adherence − concealing use of
antiretroviral medications or avoiding administration in
public settings − could prevent disclosure of status. Avoid-
ing health care settings could also mitigate status disclos-
ure and subsequent stigma, a particularly salient concern
for people who have had previous experiences of discrim-
ination within health care environments. Geurtsen et al.
(2005) indicated that for some people with HIV, avoiding
stigma could be a means of preserving one’s sense of self,
and a way to preserve dignity and a semblance of un-
altered quality of life [78].
While there may exist some potential benefit of mitigat-
ing stigma through health care utilization and adherence
practices, care avoidance practices as a stigma
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management strategy were more likely to have a negative
impact on health. Not only could care avoidance exacer-
bate health concerns, but could also contribute to coping
behaviors that put one’s health at further risk, or to self-
preservation behaviors that denied instrumental and emo-
tional support. While avoiding stigma could be considered
by some people with HIV as a means of preserving quality
of life, or saving face, it often prevented addressing stigma;
additionally, it could facilitate its internalization.
Strategies to address HIV-related stigma
A number of studies documented ways in which people
with HIV addressed stigma and discrimination, includ-
ing: social support, emotional support, practical support,
and stigma-reducing interventions. These findings illus-
trate the many approaches people with HIV and others
supporting their care can use to address stigma and its
corresponding health impacts.
Social supports were key to addressing HIV-related
stigma. People with HIV required support as they learned
to live with the infection, adhere to medication regimens,
access health care and community services, and resist the
stigmatizing experiences they faced on a daily basis. Many
people with HIV, particularly at the time of their diagnosis
desired the emotional and practical support of the people
close to them. They also made an effort to reach out and
develop connections with others who were HIV-positive.
Lindau et al. (2006) indicated the importance of peer
support for people with HIV, or gaining support from
others who knew of the stigma they faced:
“…sitting in the waiting room looking at all these
people and all these thoughts were going through my
head because I didn’t know it was a place for just
HIV. I’m looking and I’m wondering and this lady
came up to me, and she has been my friend ever since,
and she said, ‘It’s not as bad as you think it is.’ I’m
looking at her like you don’t know what my problem is.
She looked at me and said ‘I have the same thing
you’ve got and do I look like I’m dying?’ She was all
nicely groomed and nicely dressed and she was going
around smiling at everyone. And I said, ‘You don’t
know what I got.’ And she said, ‘You got the virus,
everybody here got the virus, that’s why we’re here.’ It
is really important to get that personal interaction
with other people in the same boat with you.”
(Unidentified woman quoted in Lindau, (2006), p. 66)
Some people with HIV found supportive environments
with other people with HIV as fundamental to avoiding
withdrawal and isolation. Alternatively, other people
with HIV actively sought out connections with others
outside of the HIV community as they could provide
respite from the constant reminders of being HIV
positive.
Families were also instrumental in the provision of emo-
tional support. As noted by Sayles et al. (2007), some
people with HIV reported their relationships with family
strengthened following disclosure, which allowed them to
view HIV as not just a challenge to be faced, but also as a
motivator for positive change [102].
The literature also emphasized the importance of
practical support for people living with HIV who may
have experienced social isolation due to stigma. Com-
munity programs provided important support systems
for people with HIV, at times filling in the gaps where
partners, friends, and family could not or would not offer
the necessary assistance. Compassionate health care pro-
viders also served as an essential component of the sup-
port systems of people with HIV. Rajabiun et al. (2007)
indicated that relationships with service providers could
even become the primary source of support [94]:
“Patient advocates, social workers, [everyone in this
program] it’s good to have. Because I go through a lot
of situations, like I said, I got fired . . . And it’s good to
have someone you can call to help you. They’re
patient. They will actually sit down and talk to you.
They will not blow you off. I think if it weren’t for [the
outreach program] I’ll probably still be out here in the
streets, doing the same thing, if it weren’t for this
organization.” (Unidentified participant quoted in
Rajabiun (2007), p. S-27)
Non-judgmental attitudes from health care workers
was identified as fundamental to creating a safe space
for people with HIV. Supportive attitudes from health
care workers was also discussed as facilitating health:
encouraging care seeking behaviors, motivating adher-
ence, encouraging communication, and decreasing social
isolation and exclusion.
Also identified were a variety of approaches to actively
resist and reduce stigma and discrimination. The most
common was involving people with HIV in stigma reduc-
tion strategies. For instance, people with HIV served as
self-advocates by raising awareness, educating others in
their communities, or through formal volunteerism within
ASOs. Self-advocacy also allowed people with HIV to
move away from denial about the diagnosis and towards
taking care of their health. As offered by Sayles (2007), in
communities where the threat of disclosure was great,
merely sharing one’s status openly was viewed by people
with HIV as an act of resistance [102]:
“What I did was I empowered myself by disclosing. I
went on TV, radio talk shows, and magazines.... I just
went public with my whole life and I felt like a sense
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of freedom and I gained my power. I am comfortable
with the facts and I am very realistic that I have this
virus in my body.... Right now there is no way I can get
rid of it, so therefore I must learn to live with it. I am
going to live in this world whether you like me or not.
This is my world.” (Unidentified female participant
quoted in Sayles (2007), p. 821)
Furthermore, the qualitative literature demonstrated
that people with HIV could play a significant role in
collective advocacy. The Committee for Accessible AIDS
Treatment (2008) offered the active involvement and
engagement of “PHAs” or people with HIV as instru-
mental to HIV movements [70]:
“I think we need PHA leaders… it's those early
pioneers who admitted that they were survivors of the
mental health service industry and came forward and
really challenged us and other social service
organizations to develop. I really feel strongly that
there needs to be leaders in the IRN-PHA community
who come forth. It's an unfortunate burden that they
have to bear, it's not very equitable, but I think that's
important.” (Ethno-specific ASO male quoted in CAAT
(2008), p. 33)
Other community members also acted as advocates in
stigma reduction strategies. Family, friends, health care
and social service practitioners were offered as key
players in proclaiming support for people with HIV and
in raising awareness among service providers and the
general community.
Synthesis findings illustrate that in certain conditions,
people with HIV can transform their experiences of stigma
in ways that create opportunities for empowerment and
change [117]. Notably, many of these strategies require
the support of others impacted by HIV: friends, families,
partners and the greater communities.
Discussion
This synthesis of the qualitative evidence exploring stigma,
HIV and health demonstrates that HIV-related stigma
within the health context is reflective of the society at
large, and that it is socially embedded, shaped, and influ-
enced by social and cultural mores and values, a finding
substantiated in other reviews [11, 39, 135]. Exclusively
reviewing the qualitative literature offers a nuanced under-
standing of the manifestation of stigma within health con-
texts. Particularly, it illustrates the emotional, attitudinal,
and structural dimensions of stigma as experienced by
people with HIV.
While HIV-related stigma within health care settings
has been attributed to misperceptions surrounding
transmission, findings from this synthesis also indicate
that emotions serve as a driver of HIV-related stigma.
The affective dimensions of stigma shaped practitioner
care practices even when knowledge of HIV transmis-
sion risks were available. While other reviews have noted
that practitioners’ fear of casual contact may stem from
limited information on HIV transmission risks [11], find-
ings from this review also illustrate how fears can arise
in practitioners who are knowledgeable of the risks. These
findings emphasize the psychosocial nature of stigma and
discrimination. Prejudice is a prejudgement that has both
cognitive and affective dimensions [120]. To prevent a
prejudgement from manifesting as discriminatory treat-
ment, knowledge provision must attend to both its cogni-
tive and affective aspects as emotions can overpower
rational decision making. While education has served to
mitigate some of the misperceptions surrounding HIV,
there still remains the affective dimensions that contribute
to discriminatory behaviours such as fear of transmission
through the provision of care. These findings suggest
that stigma reduction interventions for health care
practitioners must do more than relay knowledge, they
also must acknowledge and address the emotional as-
pects as well.
Along with the affective dimensions of stigma, there
also exists the attitudinal or behavioural dimensions.
These dimensions of stigma are best demonstrated when
looking at the literature exploring the moral aspects of
stigma. Particularly, synthesis findings illustrate the inter-
connections between moral attributions and the devalua-
tions of social groups disproportionately impacted by
HIV. Moral attributions become modes of enforcing dom-
inant social values, including dominant constructions of
sexuality, substance use, sex work, and mothering [88].
Additionally, HIV-related stigma ascribed to activities
deemed socially deviant consequently attach to those who
engage in such activities [121]. Thus, the moralization of
HIV and its transmission behaviours further marginalized
populations that are devalued in broader society while ra-
tionalizing discriminatory behaviours through attribution
of blame [122].
As well, this synthesis illustrates the complexities
of intersectional stigma particularly when juxtaposed
with moralization of transmission activities such as
drug use, sex work, or sexual activities outside of het-
erosexual, monogamous relationships. While Herek’s
conceptualization of symbolic stigma [8, 9] offers a
framework for understanding moralized activities be-
getting moralized identities, this review emphasizes
the synergistic connection between HIV-related stigma
and pre-existing prejudices including sexism, cis-genderism/
transphobia, heterosexism/homophobia, racism, and
Eurocentrism. Intersectional stigma within the context
of this review signifies the dynamic social processes of
marginalization that are demonstrative of cultural values,
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mores and social power [4]. As the existing literature on
sexuality, race, and gender discriminations have empha-
sized, social marginalization of populations experiencing
discrimination in general society correlates with adverse
health outcomes [123–129], many of which parallel those
correlating with HIV-related stigma. While there is a
preponderance of research examining singular forms of
oppressions and its impacts on health, only recently has
research started to examine intersectional stigma in the
context of HIV-seropositivity [130–132]. More research
examining stigma, HIV and health from an intersectional
perspective is warranted given the emerging findings from
this review.
While enacted stigma can have a profound impact on
health care access, our synthesis identifies felt stigma as
impactful on the health and well-being of people with
HIV. Consistent with the quantitative literature, avoiding
HIV-related stigma was often presented as being detri-
mental to health [52, 53]. However, the qualitative litera-
ture also noted that in some circumstances, avoiding
stigma could be a means of mitigating its effects. These
varied outcomes highlight the potential competing prior-
ities people with HIV may face when managing their
health. Managing stigma through avoiding HIV-related
health care practices can be perceived as having a poten-
tial immediate benefit to one’s mental or emotional well-
being such as reduced stress stemming from anticipated
stigma; yet, it can consequently contribute to deleterious
health outcomes in the long term [110]. Additionally,
some people with HIV may have to balance competing
priorities between individual and collective need, where
they may engage in practices to avoid stigma in order
to save face within their community, protect their
HIV-positive children from disclosure, or to protect
their loved ones from worry or secondary stigma [86,
100]. These synthesis findings illustrate the import-
ance of examining qualitative evidence collectively to
understand the nuanced nature of stigma manage-
ment and the interpersonal, intrapersonal, and social
contexts which shape health care decision making of
people with HIV.
Conversely, this synthesis demonstrates that under cer-
tain conditions, people with HIV may combat or transform
their stigma experiences in ways that create opportunities
for empowerment, resistance and social change [117]. Not-
ably, many of the strategies identified as addressing stigma
require the support of others affected by HIV: friends, fam-
ilies, partners, communities, and advocates within health
care environments. These findings indicate that stigma
management is not a sole effort, but a collective and com-
munal one as well. Other literature has also indicated the
importance of involving people with HIV in stigma reduc-
tion responses and incorporating community interventions
in stigma reduction campaigns [133].
Lastly, this synthesis of the qualitative evidence illus-
trates that HIV-related stigma within health contexts is a
global phenomenon for people with HIV. While the
dimensions of stigma were similar across studies, find-
ings from qualitative studies indicate that the manifesta-
tions of stigma within health domains are temporally
and culturally shaped. For instance, in the earlier studies,
the terminality of HIV and the fear of contagion seemed
more prominent in discriminatory health care practices
than in the more recent studies, a finding that has been
substantiated in other literature [134]. Interpretations of
stigma also differed across geographic jurisdictions. For
example, disclosure of status to family was a more typical
confidentiality violation in non-Western cultures, particu-
larly African and Asian cultures where family unity is
more culturally bound [73, 88, 100]. Yet, studies in West-
ern cultures such as Europe, Canada and the United
States, also reported examples of confidentiality violations,
particularly processes that were institutionalized or in-
tegrated into practice such as distinguishing labels on
personal records, tests or medications, or practitioners
discussing client cases in non-private spaces [60, 74].
Despite differences in the interpretation of stigma ex-
periences, the identified cases were fairly similar across
studies with examples in health care access, utilization,
adherence, and mental health, a finding also identified in
another literature review [135]. More notably, extreme
examples of stigma within health care such as blatant
disregard for confidentiality, degrading comments, hu-
miliating treatment, and denial of care were identified
across temporal and geographic contexts, including more
recent studies conducted in countries such as Canada and
the United States, where stigma is a focal point of HIV
education and modes of transmission are commonly pro-
moted to the general public. While HIV-related stigma is
a global phenomenon, future research on HIV-related
stigma and stigma reduction strategies should consider
local manifestation of stigma within the health context as
well as how stigma can be differentially experienced across
cultures.
Findings from this qualitative synthesis indicate that
combating HIV-related stigma within health care envi-
ronments and addressing the health-related effects will
require more than targeted interventions directed towards
health care practitioners or individuals with HIV. While
stigma reducing interventions for people with HIV can
mitigate some individual health effects of felt stigma, they
do not address its social embeddedness which fosters
enacted stigma. While HIV education may address overt
forms of HIV-related discrimination, it cannot illustrate
the subtle ways that activities within health care settings
can be stigmatizing nor will it address the structural
dimensions of stigma within society at large. Some of the
challenges of combating HIV-related stigma within health
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care settings stem from structural factors such as discrim-
ination of people with HIV within other social spheres,
limited legislation prohibiting discrimination of people
with HIV, and discriminatory practices embedded within
jurisdictional legislation [136]. Recent evidence emphasizes
that stigma reduction interventions within health care
settings should also address discrimination within institu-
tional culture as well as factors that foster HIV-related
stigma at the individual, environmental and societal levels
[137]. Furthermore, HIV-related stigma intersects with
many other forms of marginalization − sexual identity, gen-
der identity, race, ethnicity, socioeconomic status, class or
caste, for example. Undertaking intersectional stigma re-
quires a multidimensional approach in order to address its
mutual constitutiveness. Review findings demonstrate that
tackling HIV-related stigma will require acknowledgement
and address of other forms of discrimination that dispro-
portionately intersect with HIV.
Therefore, findings of this synthesis indicate that to
reduce HIV-related stigma − the third phase of the HIV
epidemic identified twenty-five years ago that still exists
to this day − local and global interventions, and future
stigma research will need to consider the social struc-
tures and societal practices, within and outside of health
care environments, that perpetuate and reinforce stigma
and discrimination towards people with HIV.
Strengths and limitations of this synthesis
This qualitative synthesis performed a comprehensive
search of the peer-reviewed literature, used a consensus
approach to select and extract data from relevant papers,
and presented detailed information of included studies
and thematically summarized the findings. As with any
other systematic review, it also had a few limitations. In
the analysis we were unable to include studies published
in languages other than English, French or Spanish. The
search strategy did not include an electronic database
search for grey literature, although we did conduct man-
ual searches that could capture non-peer reviewed or
unpublished literature. Even though the included findings
were geographically diverse, study definitions derived from
Westernized knowledge of stigma and health, and may
not have aptly captured non-Western or Indigenous con-
ceptualizations of these terms.
Conclusions
The synthesis of the qualitative evidence identified 55
qualitative studies that illustrate HIV-related stigma in the
context of health. HIV-related stigma is a psychological
and social process in which HIV-positive individuals
struggle to cope with the misperceptions, social separ-
ation, denigration, and discriminatory actions associated
with their status. Findings from this synthesis indicate that
HIV-related stigma is a global social phenomenon for
people with HIV that manifests within multiple social
spheres, including health care environments. The qualita-
tive literature identifies a number of strategies used within
health care settings − some rooted in institutional prac-
tices, others shaped by personal perceptions held by prac-
titioners − that could subsequently be stigmatizing or
discriminatory for people with HIV. The literature also
identifies strategies people with HIV may use to manage
stigma as they utilize health care or adhere to treatment
regimes. While some stigma management strategies may
mitigate the mental health impacts of stigma, others may
put one’s health at risk. These health care strategies re-
lated to HIV and stigma suggest the dynamic interconnec-
tions of enacted and felt stigma along with
marginalization, moralization, disclosure, and the visibility
of HIV/AIDS as a health condition.
Findings from qualitative evidence also suggest modes
of addressing stigma that can disrupt this cyclical
process. The literature identifies a number of ways to
address stigma and its health impacts including social
support, education, self-efficacy and resilience strategies,
and social and individual advocacy. Since stigma and
discrimination incorporates cognitive, affective, attitu-
dinal and behavioural dimensions and is experienced
and enacted at individual, community, and societal levels,
multi-dimensional, multi-level societal responses to HIV-
related stigma are required to address all of these aspects.
While people impacted by HIV should shape stigma
reduction strategies, it will take a collective, societal
response to combat HIV-related stigma and its health
effects.
Endnotes
1Of the 11 foreign language papers, four each were
published in Chinese and Portuguese, and one each were
published in Czech, German, and Serbian.
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